Mo1869 SUBCUTANEOUS INFLIXIMAB EFFECTIVELY MANAGES CLINICAL OUTCOMES OF INFLAMMATORY BOWEL DISEASE INDEPENDENTLY OF VARIOUS CONFOUNDING FACTORS
Gastroenterology(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined